Document Detail

Saccharomyces boulardii fungemia caused by treatment with a probioticum.
MedLine Citation:
PMID:  22605806     Owner:  NLM     Status:  MEDLINE    
Saccharomyces cerevisiae, known as baker's yeast, is normally considered a non-pathogenic yeast. A genetically very similar subtype, S boulardii, is used in a probioticum (Sacchaflor) to prevent antibiotic-associated diarrhoea and in the treatment of recurrent Clostridium difficile associated diarrhoea. The authors present a case report of a 79-year-old woman with rheumatoid arthritis, who after a bowel resection developed S boulardii fungemia. Her postoperative course was complicated by nutritional problems, anaemia and several nosocomial infections including recurrent C difficile associated diarrhoea. The diarrhoea was treated with metronidazole, vancomycin and Sacchaflor. After 13 days of treatment, the patient developed fungemia with S boulardii. Treatment with Sacchaflor was immediately discontinued and the patient was successfully treated with amphotericin B. Fungemia is a rare, but a serious complication to treatment with probiotics. Accordingly, the authors find it important to remind the clinicians of this risk when prescribing probiotics especially to immunocompromised patients.
Julie Bjerre Thygesen; Henning Glerup; Britta Tarp
Related Documents :
24094016 - Comparative evaluation of cephalometric occlusal characteristics between the long face ...
18534506 - Periacetabular osteotomy and total hip arthroplasty in patients older than 40 years.
7906386 - Evaluation of the quality of life associated with zidovudine treatment in asymptomatic ...
23998146 - Can new dentures decrease candida levels?
23231426 - Comparison of video laryngoscopy and direct laryngoscopy in a critical care transport s...
18276166 - Elective shoulder arthroplasty in patients older than ninety years of age.
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2012-03-27
Journal Detail:
Title:  BMJ case reports     Volume:  2012     ISSN:  1757-790X     ISO Abbreviation:  BMJ Case Rep     Publication Date:  2012  
Date Detail:
Created Date:  2012-05-18     Completed Date:  2013-02-12     Revised Date:  2014-03-28    
Medline Journal Info:
Nlm Unique ID:  101526291     Medline TA:  BMJ Case Rep     Country:  England    
Other Details:
Languages:  eng     Pagination:  -     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amphotericin B / therapeutic use
Antifungal Agents / therapeutic use
Enterocolitis, Pseudomembranous / drug therapy*
Fungemia / chemically induced*,  drug therapy
Probiotics / adverse effects*
Reg. No./Substance:
0/Antifungal Agents; 7XU7A7DROE/Amphotericin B

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Flash pulmonary oedema: a rare but serious side effect of quinine sulphate.
Next Document:  Tuberculosis of sacrum mimicking as malignancy.